| BE0321-5MG
| InVivoMAb anti-mouse NKG2A/C/E
| 5 mg
| BioXCell
| in vivo NKG2A blockade, in vitro NKG2A blockade, I
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0343-100MG
| InVivoMAb anti-human CD71 (TfR)
| 100 mg
| BioXCell
| Western blot, Immunoprecipitation, Flow cytometry
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0312-5MG
| InVivoMAb anti-mouse IFN?
| 5 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0359-50MG
| InVivoMAb anti-SARS-CoV-2 S protein (RBD epitope B)
| 50 mg
| BioXCell
| in vitro blocking of SARS-CoV-2 S protein, Flow cy
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0372-1MG
| InVivoMAb anti-mouse osteopontin (SPP1)
| 1 mg
| BioXCell
| in vivo OPN neutralization, in vitro OPN neutraliz
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0313-100MG
| InVivoMAb anti-mouse IL-23 (p19)
| 100 mg
| BioXCell
| in vivo IL-23p19 neutralization; Western blot
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BP0001-1-25MG
| InVivoPlus anti-mouse CD3?
| 25 mg
| BioXCell
| in vivo T cell depletion, in vitro T cell stimulat
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0370-1MG
| InVivoMAb anti-human CD71 (TfR1)
| 1 mg
| BioXCell
| Flow cytometry, Immunoprecipitation
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0305-1MG
| InVivoMAb anti-mouse CLEC9A (CD370)
| 1 mg
| BioXCell
| in vivo Ag targeting to CLEC9A+ DCs, Western blot,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0367-1MG
| InVivoMAb anti-human CD71 (TfR1)
| 1 mg
| BioXCell
| in vitro CD71 targeting, in vivo CD71 targeting, I
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0374-25MG
| InVivoMAb anti-mouse FAP
| 25 mg
| BioXCell
| Chimeric antigen receptor construction, Flow cytom
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0304-25MG
| InVivoMAb anti-mouse BTLA (CD272)
| 25 mg
| BioXCell
| in vivo BTLA+ B cell and CD4 T cell depletion, Flo
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0364-25MG
| InVivoMAb anti-mouse BTLA (CD272)
| 25 mg
| BioXCell
| in vivo BTLA blockade, Flow cytometry
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0301-50MG
| InVivoMAb human IgG2 isotype control
| 50 mg
| BioXCell
|
|
| Human
| N/
| Solicitar Precio
| Solicitar
|
| BE0332-5MG
| InVivoMAb anti-mouse FGL-1
| 5 mg
| BioXCell
| in vivo FGL-1 blockade, in vitro FGL-1 blockade, F
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0336-5MG
| InVivoMAb anti-human MUC1 (CD227)
| 5 mg
| BioXCell
| in vivo administration in mouse xenograft models,
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0325-5MG
| InVivoMAb anti-West Nile/dengue virus E protein
| 5 mg
| BioXCell
| Neutralization of WNV, Neutralization of DENV1,2,3
|
| Mouse
| West Nile/dengue viru
| Solicitar Precio
| Solicitar
|
| BE0365-100MG
| InVivoMAb anti-mouse CD80 (B7-1)
| 100 mg
| BioXCell
| in vivo CD80 blockade, in vitro CD80 blockade, Flo
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0311-50MG
| InVivoMAb anti-mouse CD317 (BST2, PDCA-1)
| 50 mg
| BioXCell
| in vivo pDC depletion, Immunofluorescence, Flow cy
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0325-25MG
| InVivoMAb anti-West Nile/dengue virus E protein
| 25 mg
| BioXCell
| Neutralization of WNV, Neutralization of DENV1,2,3
|
| Mouse
| West Nile/dengue viru
| Solicitar Precio
| Solicitar
|
| BE0298-1MG
| InVivoMAb anti-mouse CD122 (IL-2R?)
| 1 mg
| BioXCell
| in vivo NK cell depletion, in vitro IL-2R blockade
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0321-100MG
| InVivoMAb anti-mouse NKG2A/C/E
| 100 mg
| BioXCell
| in vivo NKG2A blockade, in vitro NKG2A blockade, I
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0334-50MG
| InVivoMAb anti-mouse NKG2D (CD314)
| 50 mg
| BioXCell
| in vivo NKG2D blockade, in vitro NKG2D blockade, F
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0358-25MG
| InVivoMAb anti-SARS-CoV-2 S protein (NTD)
| 25 mg
| BioXCell
| Flow cytometry, ELISA
|
| Mouse
| Virus
| Solicitar Precio
| Solicitar
|
| BE0367-25MG
| InVivoMAb anti-human CD71 (TfR1)
| 25 mg
| BioXCell
| in vitro CD71 targeting, in vivo CD71 targeting, I
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0354-50MG
| InVivoMAb anti-human CD2
| 50 mg
| BioXCell
| in vivo CD2 blockade in huCD2tg mice
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0310-1MG
| InVivoMAb anti-mouse VISTA
| 1 mg
| BioXCell
| in vivo blocking of VISTA signaling, in vitro bloc
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0330-5MG
| InVivoMAb anti-mouse CD69
| 5 mg
| BioXCell
| in vivo down-regulation of CD69 expression, Functi
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0328-5MG
| InVivoMAb anti-mouse CD28
| 5 mg
| BioXCell
| in vivo T cell stimulatioN/Activation, in vitro T
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0375-50MG
| InVivoMAb anti-human EGFR
| 50 mg
| BioXCell
| in vitro EGFR blockade, in vivo EGFR blockade in x
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0299-1MG
| InVivoMAb anti-mouse CD200 (OX2)
| 1 mg
| BioXCell
| in vivo CD200 blockade, in vitro CD200 blockade, I
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0360-1MG
| InVivoMAb anti-mouse CD24
| 1 mg
| BioXCell
| in vivo administration, Immunohistochemistry (froz
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0341-1MG
| InVivoMAb anti-human EphA2
| 1 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunoprecipitati
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0341-5MG
| InVivoMAb anti-human EphA2
| 5 mg
| BioXCell
| Immunohistochemistry (paraffin), Immunoprecipitati
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0323-100MG
| InVivoMAb anti-mouse TL1A (TNFSF15)
| 100 mg
| BioXCell
| in vivo TL1A neutralization, Flow cytometry
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0302-50MG
| InVivoMAb anti-mouse CD20
| 50 mg
| BioXCell
| Flow cytometry, Western blot
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0317-50MG
| InVivoMAb anti-mouse CD38
| 50 mg
| BioXCell
| in vivo CD38 stimulation, in vitro CD38 stimulatio
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0318-5MG
| InVivoMAb anti-human Ganglioside GD2
| 5 mg
| BioXCell
| in vitro induction of apoptosis in GD2+ cells, in
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0316-25MG
| InVivoMAb anti-mouse CCR3 (CD193)
| 25 mg
| BioXCell
| in vivo eosinophil depletion
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0324-25MG
| InVivoMAb anti-human/mouse denatured collagen type-I (RGD motif)
| 25 mg
| BioXCell
| Western blot, Immunofluorescence, in vivo adminis
|
| Mouse
| human/mous
| Solicitar Precio
| Solicitar
|
| BE0312-100MG
| InVivoMAb anti-mouse IFN?
| 100 mg
| BioXCell
| in vivo IFN? neutralization, in vitro IFN? neutral
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0346-5MG
| InVivoMAb anti-mouse CD326 (EpCAM)
| 5 mg
| BioXCell
| Immunohistochemistry (frozen), Immunofluorescence,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0317-100MG
| InVivoMAb anti-mouse CD38
| 100 mg
| BioXCell
| in vivo CD38 stimulation, in vitro CD38 stimulatio
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0329-1MG
| InVivoMAb anti-mouse CD71 (TfR1)
| 1 mg
| BioXCell
| in vivo depletion of CD71+ cells, Immunofluorescen
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0351-25MG
| InVivoMAb anti-human NKG2D (CD314)
| 25 mg
| BioXCell
| in vitro NKG2D blocking, Immunoprecipitation, Flow
|
| Mouse
| Human
| Solicitar Precio
| Solicitar
|
| BE0307-50MG
| InVivoMAb anti-mouse CD16/CD32
| 50 mg
| BioXCell
| in vitro Fc receptor blocking, in vivo Fc receptor
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0378-1MG
| InVivoMAb anti-mouse CD16.2 (Fc?RIV)
| 1 mg
| BioXCell
| in vivo CD16.2 blockade, in vitro CD16.2 blockade,
|
| Armenian Hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0305-5MG
| InVivoMAb anti-mouse CLEC9A (CD370)
| 5 mg
| BioXCell
| in vivo Ag targeting to CLEC9A+ DCs, Western blot,
|
| Rat
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0323-25MG
| InVivoMAb anti-mouse TL1A (TNFSF15)
| 25 mg
| BioXCell
| in vivo TL1A neutralization, Flow cytometry
|
| Armenian hamster
| Mouse
| Solicitar Precio
| Solicitar
|
| BE0356-5MG
| InVivoMAb anti-mouse CD20
| 5 mg
| BioXCell
| in vivo B cell depletion, Western blot
|
| Mouse
| Mouse
| Solicitar Precio
| Solicitar
|